XPEL (XPEL) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for June 4, 2025, with voting on director elections, auditor ratification, executive compensation, and a new Employee Stock Purchase Plan.
Proxy materials distributed primarily via internet to reduce costs and environmental impact.
Record date for voting is April 15, 2025, with 27,664,765 shares outstanding.
2024 saw revenue growth of 6.1% to $420.4M, but net income declined 13.8% to $45.5M.
Voting matters and shareholder proposals
Proposals include election of five directors, ratification of Deloitte & Touche LLP as auditor, advisory vote on executive compensation, and approval of the 2025 Employee Stock Purchase Plan.
Board recommends voting FOR all proposals.
Shareholder proposals for the 2026 meeting must be submitted by December 26, 2025.
Board of directors and corporate governance
Board consists of five nominees, with a majority deemed independent under Nasdaq standards.
Committees: Audit (Klonne, Crumly, North), Compensation (North, Crumly, Bogart), Nominating and Corporate Governance (Bogart, Crumly, Klonne).
All directors attended at least 75% of meetings in 2024.
Board leadership combines CEO and Chairman roles, with regular executive sessions of independent directors.
Stockholder communications and director nominations are facilitated through established processes.
Latest events from XPEL
- Q4 revenue up 13.7% and EBITDA up 37.6%, with strong gains in China and margin expansion.XPEL
Q4 202525 Feb 2026 - Record Q2 revenue and cash flow, with robust US/service growth despite China weakness.XPEL
Q2 20242 Feb 2026 - All proposals passed, board re-elected, and no questions were raised during the meeting.XPEL
AGM 20241 Feb 2026 - Q3 revenue hit $112.9M (+9.9% YoY) with strong US and window film growth.XPEL
Q3 202415 Jan 2026 - Q3 2025 revenue up 11.1% to $125.4M; net income down 11.8% amid margin pressure.XPEL
Q3 202514 Jan 2026 - 2024 revenue up 6.1% to $420.4M, but net income and EBITDA fell; 2025 outlook remains mixed.XPEL
Q4 202423 Dec 2025 - Director elections, auditor ratification, and compensation plan up for shareholder vote.XPEL
Proxy Filing1 Dec 2025 - Q2 2025 delivered record revenue, profit growth, and strong international momentum.XPEL
Q2 202523 Nov 2025 - Q1 2025 revenue up 15.2%, net income up 28.8%, $50M buyback amid tariff uncertainty.XPEL
Q1 202521 Nov 2025